Render Target: STATIC
Render Timestamp: 2024-12-02T11:32:56.766Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-09-30 01:59:49.854
Product last modified at: 2024-11-03T14:15:07.463Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

CX3CR1 (E9J4I) Rabbit mAb #19771

Filter:
  • F

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa)
    Source/Isotype Rabbit IgG
    Application Key:
    • F-Flow Cytometry 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Flow Cytometry (Live) 1:50 - 1:200

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    CX3CR1 (E9J4I) Rabbit mAb recognizes endogenous levels of total CX3CR1 protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human CX3CR1 protein.

    Background

    CX3C chemokine receptor 1 (CX3CR1) is a member of the seven-transmembrane G-protein coupled receptor (GPCR) family. It is a receptor for its sole ligand, CX3CL1, also known as fractalkine or neurotactin (1). Immune cells that express CX3CR1 include monocytes, macrophages, microglia, T helper (Th) 1 cells, CD8+ T effector/memory cells, NK cells, γδ T cells, and dendritic cells (DCs) (1,2). CX3CR1 has been implicated in inflammatory diseases, such as nephropathy and macular degeneration, and HIV co-receptors. It is emerging as an important player in the regulation of insulin secretion and beta cell function (3). In the brain, CX3CR1 expression is microglia-specific and regulates microglial recruitment to sites of neuroinflammation (1,2). Disruption of CX3CL1-CX3CR1 signaling promotes neurodegeneration in mouse models of Parkinson’s disease and amyotrophic lateral sclerosis but might be protective in Alzheimer’s disease (AD) (2,4,5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    Cy and CyDye are registered trademarks of GE Healthcare.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.